Company intelligence / Profile preview
Gibson Oncology
Miami, Florida, United Statesgibsononcology.com ↗
- Ownership
- Private
- Development stage
- Phase 2
01
Overview
Multiple Phase 1 FDA clinical trials completed by the National Cancer Institute showing safety and efficacy in over 70 end-stage cancer patients with solid tumors who had failed previous treatments. The drugs demonstrated effectiveness while reducing incidence of grade 3 and 4 neutropenia and diarrhea[1][3].
- Therapeutic areas
- Oncology
- Modalities
- Small molecules (indenoisoquinolines/"indenos")
- Industry
- Biotech
02
Drug pipeline
3 assets2 more assets in the full pipeline.
Request access →03
Partnerships
National Cancer Institute (NCI)Purdue UniversityNIHRobert Preston Tisch Brain Tumor Center at Duke University
Beyond the preview
Go deeper on Gibson Oncology.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Gibson Oncology.